Robert W. Katzman, MD, Clinical Research Training Scholarship in Alzheimer's and Dementia Research

Sponsor: Alzheimer's Association, American Brain Foundation, and American Academy of Neurology

Award: $150,000

Due Date: October 1, 2019

Service Network Hub for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) (RFA-RM-19-010)

Sponsor: Office of Strategic Coordination (Common Fund)

Award: The NIH Common Fund intends to commit approximately $7.175 million in FY 2020 to fund one award.

Due Date: November 12 , 2019, by 5 p.m. local time of applicant organization.

National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate (T34) (PAR-19-299)

Sponsor: National Institute of General Medical Sciences

Due Date: September 25, 2019; September 25, 2020; September 27, 2021, by 5 p.m. local time of applicant organization.

National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) (PAR-19-300)

Sponsor: National Institute of General Medical Sciences

Due Date: September 25, 2019; September 25, 2020; September 27, 2021, by 5 p.m. local time of applicant organization.

Service Centers for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) (RFA-RM-19-009)

Sponsor: Office of Strategic Coordination (Common Fund)

Award: The NIH Common Fund intends to commit approximately $6.8 million in FY 2020 to fund four awards.

Due Date: November 12, 2019, by 5 p.m. local time of applicant organization.

Essential Open Source Software for Science

Sponsor: The Chan Zuckerberg Initiative

Award: Applicants can request funding between $50,000 and $250,000 for one year.

Due Date: CZI will invite applications during three distinct cycles, with rounds beginning June 18, 2019; mid-December 2019; and mid-June 2020.

Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) (PAR-19-298)

Sponsor: National Institute on Aging, National Institute of Mental Health

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2019.

Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed) (RFA-AG-20-007)

Sponsor: National Institute on Aging

Award: NIA intends to commit $787,500 in FY 2020 to fund two awards.

Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.

Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional) (RFA-AG-20-022)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3 million in FY 2020 to fund four to six awards.

Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.

Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID) (R01 Clinical Trial Not Allowed) (RFA-NS-19-039)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: NINDS intends to commit up to $3.75 million in FY 2020 to fund up to six awards.

Due Date: August 14, 2019, by 5 p.m. local time of applicant organization.

Rare As One Project

Sponsor: Chan Zuckerberg Initiative

Due Date: Letters of Interest due July 23, 2019.

Alzheimer’s and Infectious Diseases Research Grants

Sponsor: Infectious Diseases Society of America (IDSA) Foundation

Award: The IDSA Foundation is offering up to five one-time, $100,000 grants to researchers working to identify a microbial link to Alzheimer’s disease.

Due Date: The application period for the grant will open on June 10, and remain open through November 30.

Interpersonal Processes in Alzheimer's Disease and Related Dementias Clinical Interactions and Care Partnerships (R01 Clinical Trial Optional) (RFA-AG-20-006)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3 million in FY 2020 to fund four to six awards.

Due Date: October 23, 2019, by 5 p.m. local time of applicant organization.

Prevention Beyond the Pipeline

Sponsor: Alzheimer's Drug Discovery Foundation

Award: $50,000-$100,000 for epidemiological analyses based on scope of research. Up to $3 million for clinical trials based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Due Date: Letter of Intent, July 12, 2019, Invited Full Proposal, August 9, 2019; Letter of Intent, October 11, 2019, Invited Full Proposal, November 8, 2019.

Program to Accelerate Clinical Trials

Sponsor: Alzheimer's Drug Discovery Foundation

Award: Up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Due Date: Letter of Intent, July 12, 2019, Invited Full Proposal, August 9, 2019, Letter of Intent, October 11, 2019, Invited Full Proposal, November 8, 2019.